The National Conference Center , Lansdowne, VA USA
Nov 2 2011 8:00AM - 5:00PM
November 2, 2011 or November 3, 2011 Two 1-Day Workshops National Conference Center (NCC), Lansdowne, VA Registration is limited (maximum of 3 persons per organization) and is accepted on a first come—first served basis. Please select your specifi ed date of preference for attendance. Registration closes October 24, 2011; on-site registration will not be available for this workshop. In Collaboration with the National Organization for Rare Disorders (NORD) and Genetic Alliance FDA is pleased to announce the continuation of the Orphan Drug Designation Workshop series, presenting an opportunity for academics, biotechnology companies and larger pharmaceutical fi rms to spend a full day in creation of applications for orphan status designation. This workshop is designed to simplify and demystify entry into orphan drug development by small biotechnology companies, academics and larger industry entities. Event Code:
11040
|